Search Results

There are 13277 results for: content related to: Determination of chitin content in fungal cell wall: An alternative flow cytometric method

  1. Pharmacoeconomic analysis of voriconazole vs. caspofungin in the empirical antifungal therapy of febrile neutropenia in Australia


    Volume 55, Issue 3, May 2012, Pages: 244–256, Daoud Al-Badriyeh, Danny Liew, Kay Stewart and David C. M. Kong

    Version of Record online : 26 JUL 2011, DOI: 10.1111/j.1439-0507.2011.02074.x

  2. Safety and Pharmacokinetics of Higher Doses of Caspofungin in Healthy Adult Participants

    The Journal of Clinical Pharmacology

    Volume 51, Issue 2, February 2011, Pages: 202–211, Dr Elizabeth M. Migoya, Mr Goutam C. Mistry, Dr Julie A. Stone, Dr Wendy Comisar, Dr Peng Sun, Ms Alisha Norcross, Mr Sheng Bi, Dr Gregory A. Winchell, Dr Kalyan Ghosh, Dr Naoto Uemera, Dr Paul J. Deutsch and Dr John A. Wagner

    Version of Record online : 7 MAR 2013, DOI: 10.1177/0091270010374853

  3. Single- and Multiple-Dose Administration of Caspofungin in Patients With Hepatic Insufficiency: Implications for Safety and Dosing Recommendations

    The Journal of Clinical Pharmacology

    Volume 47, Issue 8, August 2007, Pages: 951–961, Mr. Goutam C. Mistry, Dr. Elizabeth Migoya, Dr. Paul J. Deutsch, Dr. Gregory Winchell, Mr. Michael Hesney, Ms Susan Li, Ms Sheng Bi, Ms Stacy Dilzer, Dr. Kenneth C. Lasseter and Dr. Julie A. Stone

    Version of Record online : 7 MAR 2013, DOI: 10.1177/0091270007303764

  4. Intraocular caspofungin: in vitro safety profile for human ocular cells


    Volume 54, Issue 4, July 2011, Pages: e110–e121, M. Kernt and A. Kampik

    Version of Record online : 19 FEB 2010, DOI: 10.1111/j.1439-0507.2009.01853.x

  5. You have full text access to this OnlineOpen article
    Caspofungin for post solid organ transplant invasive fungal disease: results of a retrospective observational study

    Transplant Infectious Disease

    Volume 12, Issue 3, June 2010, Pages: 230–237, M. Winkler, J. Pratschke, U. Schulz, S. Zheng, M. Zhang, W. Li, M. Lu, D. Sgarabotto, G. Sganga, P. Kaskel, S. Chandwani, L. Ma, J. Petrovic and M. Shivaprakash

    Version of Record online : 11 JAN 2010, DOI: 10.1111/j.1399-3062.2009.00490.x

  6. You have free access to this content
    Echinocandins in antifungal pharmacotherapy

    Journal of Pharmacy and Pharmacology

    Akash Patil and Soumyajit Majumdar

    Version of Record online : 26 JUL 2017, DOI: 10.1111/jphp.12780

  7. Lack of Pharmacokinetic Drug Interaction Between Oral Posaconazole and Caspofungin or Micafungin

    The Journal of Clinical Pharmacology

    Volume 51, Issue 1, January 2011, Pages: 84–92, Dr Gopal Krishna, Dr Donna Vickery, Lei Ma, Dr Xin Yu, Dr Carl Noren, Dr Edward Power, Dr Eric Beresford and Dr Matthew Medlock

    Version of Record online : 8 MAR 2013, DOI: 10.1177/0091270009360982

  8. Plasma concentrations of caspofungin at two different dosage regimens in a patient with hepatic dysfunction

    Transplant Infectious Disease

    Volume 14, Issue 4, August 2012, Pages: 440–443, K.C.M. van der Elst, R.J.M. Brüggemann, M.G.G. Rodgers and J.W.C. Alffenaar

    Version of Record online : 9 FEB 2012, DOI: 10.1111/j.1399-3062.2011.00716.x

  9. The Echinocandins

    Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy

    Volume 27, Issue 3, March 2007, Pages: 369–388, Diane Cappelletty and Kasi Eiselstein-McKitrick

    Version of Record online : 6 JAN 2012, DOI: 10.1592/phco.27.3.369

  10. Comedication of caspofungin acetate and cyclosporine A after allogeneic haematopoietic stem cell transplantation leads to negligible hepatotoxicity


    Volume 51, Issue s1, July 2008, Pages: 19–24, Maximilian Christopeit, Martin Eikam and Gerhard Behre

    Version of Record online : 8 MAY 2008, DOI: 10.1111/j.1439-0507.2008.01524.x

  11. Poster Presentations


    Volume 52, Issue s1, October 2009, Pages: 29–123,

    Version of Record online : 16 SEP 2009, DOI: 10.1111/j.1439-0507.2009.01782.x

  12. You have free access to this content
    Efficacy of caspofungin against invasive Candida or invasive Aspergillus infections in neutropenic patients


    Volume 106, Issue 2, 15 January 2006, Pages: 466–473, Robert Betts, Axel Glasmacher, Johan Maertens, Georg Maschmeyer, Jose A. Vazquez, Hedy Teppler, Arlene Taylor, Robert Lupinacci, Carole Sable and Nicholas Kartsonis

    Version of Record online : 13 DEC 2005, DOI: 10.1002/cncr.21615

  13. You have free access to this content
    A retrospective nationwide case study on the use of a new antifungal agent: patients treated with caspofungin during 2001–2004 in Finland

    Clinical Microbiology and Infection

    Volume 13, Issue 6, June 2007, Pages: 606–612, V.-J. Anttila, J. Salonen, P. Ylipalosaari, I. Koivula, P. Riikonen and J. Nikoskelainen

    Version of Record online : 22 MAR 2007, DOI: 10.1111/j.1469-0691.2007.01709.x

  14. You have free access to this content
    The Candida albicans Cdr2p ATP-binding cassette (ABC) transporter confers resistance to caspofungin

    Molecular Microbiology

    Volume 48, Issue 1, April 2003, Pages: 225–235, Manuela Schuetzer-Muehlbauer, Birgit Willinger, Gerd Krapf, Sabine Enzinger, Elisabeth Presterl and Karl Kuchler

    Version of Record online : 25 MAR 2003, DOI: 10.1046/j.1365-2958.2003.03430.x

  15. Assessing the antifungal activity and toxicity profile of amphotericin B lipid complex (ABLC; Abelcet®) in combination with caspofungin in experimental systemic aspergillosis

    Journal of Pharmaceutical Sciences

    Volume 93, Issue 6, June 2004, Pages: 1382–1389, Olena Sivak, Karen Bartlett, Verica Risovic, Eugene Choo, Fawziah Marra, D. Scotty Batty Jr. and Kishor M. Wasan

    Version of Record online : 26 MAR 2004, DOI: 10.1002/jps.20080

  16. Combination of caspofungin and low-dose trimethoprim/sulfamethoxazole for the treatment of severe Pneumocystis jirovecii pneumonia in renal transplant recipients


    Volume 18, Issue 11, November 2013, Pages: 736–742, Guo-wei Tu, Min-jie Ju, Ming Xu, Rui-ming Rong, Yi-zhou He, Zhang-gang Xue, Tong-yu Zhu and Zhe Luo

    Version of Record online : 23 OCT 2013, DOI: 10.1111/nep.12133

  17. You have free access to this content

    Clinical Microbiology and Infection

    Volume 13, Issue s1, April 2007, Pages: S109–S608,

    Version of Record online : 26 MAR 2007, DOI: 10.1111/j.1469-0691.2007.01733.x

  18. Clinical evidence for caspofungin monotherapy in the first-line and salvage therapy of invasive Aspergillus infections


    Volume 59, Issue 8, August 2016, Pages: 480–493, Werner J. Heinz, Dieter Buchheidt and Andrew J. Ullmann

    Version of Record online : 21 JUN 2016, DOI: 10.1111/myc.12477

  19. You have free access to this content
    Economic Evaluation of Caspofungin versus Liposomal Amphotericin B for Empiric Antifungal Treatment in Patients with Neutropenic Fever in Italy

    Value in Health

    Volume 11, Issue 5, September/October 2008, Pages: 830–841, Wiro B. Stam, Franco Aversa, Ritesh N. Kumar and Jeroen P. Jansen

    Version of Record online : 20 MAY 2008, DOI: 10.1111/j.1524-4733.2008.00324.x

  20. Experiences with the use of caspofungin in paediatric patients


    Volume 51, Issue s1, July 2008, Pages: 58–64, Thomas Lehrnbecher and Andreas H. Groll

    Version of Record online : 8 MAY 2008, DOI: 10.1111/j.1439-0507.2008.01529.x